Delivery Order 75N94020D00004-75N94025F00001
Award Date
8/1/25
Potential Completion Date
12/31/28
Potential Value
$719K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Boston, MA 02118, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the Contraceptive Clinical Trials Network - Female Sites Evaluation of LARCs Study, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC). The $639,028.72 cost-reimbursement contract has an ultimate completion date of July 14, 2026. BMC, a major safety-net hospital and academic medical center, will provide services related to the Contraceptive Clinical Trials Network, which...
Boston Medical Center Corporation is providing clinical trial network services under a $678,333 delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle through the National Institutes of Health National Institute of Child Health and Human Development. As the prime contractor, BMC will support the Evaluation of LARCs Study as a clinical research site. No set-aside designation was applied to this order to evaluate long-acting reversible contraceptive methods....
Boston Medical Center Corporation was awarded a $108,311.84 cost-no-fee delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development. This delivery order calls for BMC to provide assistance in protocol review, protocol development, and other activities associated with the past, present, and future of the Contraceptive Clinical...
This is a Delivery Order under Contract 75N94020D00004 awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC) for a clinical trial of the OVAPRENE vaginal device. The award has a ceiling value of $126,095 and a period of performance through November 30, 2025. The contract is for TASK ORDER 2: OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPR. BMC is a major safety-net hospital and...
This federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, is for $2,032,799.45 to provide statistical and clinical coordinating services for a study evaluating the pharmacokinetics and pharmacodynamics of intramuscular or subcutaneous injections of levonorgestrel butanoate for female contraception. The contract was awarded to Health Decisions, Inc., a for-profit clinical research organization located in Morrisville, North...
This is a $506,576 delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD) to Eastern Virginia Medical School (EVMS) to conduct pharmacokinetic and pharmacodynamic evaluations of the contraceptive drug levonorgestrel butanoate. The contract is part of NICHD's Contraceptive Clinical Trials Network program and does not utilize a set-aside designation. The award period runs through July 2026. EVMS, a private medical school, has received numerous...
This federal contract award, valued at $700,938.50, was issued by the National Institute of Child Health and Human Development (NICHD) to New York University School of Medicine. The contract is for a randomized controlled study to evaluate the efficacy, safety, and acceptability of the C31G female contraceptive. This contract is part of NICHD's broader Contraceptive Efficacy Evaluation of the PATH Female Condom program. The contract is a delivery order with a cost-no-fee pricing type, and the...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Boston Medical Center Corporation (BMC), a private, not-for-profit academic medical center. The contract is a Delivery Order under the Clinical Immunization Safety Assessment (CISA) Master IDIQ, with a potential value of $728,754.00. BMC has provided clinical immunization safety assessment services to support the Department of Health and Human Services' immunization...
This is a federal contract award to Boston Medical Center Corporation (BMC), a major safety-net hospital and academic medical center in Boston, Massachusetts. The contract was awarded by the Centers for Disease Control and Prevention (CDC) to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a $742,721 delivery order under the CISA master IDIQ contract, which has a ceiling value of $86 million and runs from 2023 to 2028. The contract is not set aside. BMC is a...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to New York University (NYU) School of Medicine. The $31,304.31 contract is for the clinical evaluation of levonorgestrel butanoate for female contraception. The award does not have a set-aside designation. NYU School of Medicine is a leading academic medical center and research institution that conducts extensive...